GHK-Cu Copper Peptide Therapy
A naturally occurring copper peptide that declines with age. GHK-Cu activates growth factors that drive hair follicle regeneration, collagen synthesis, wound healing, and cellular repair. One peptide, multiple systems.
Your body produces GHK-Cu throughout life. The problem is that plasma levels at 60 are a fraction of what they were at 20. Restoring those levels reactivates biological processes that have been progressively slowing down.
What is GHK-Cu? Why It Matters as You Age
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a tripeptide that occurs naturally in human plasma, saliva, and urine. In young adults, plasma GHK-Cu concentrations are relatively high, supporting tissue repair, collagen production, and cellular regeneration. By age 60, levels have dropped by over 60% from their peak. The biological processes GHK-Cu regulates do not stop working, they just do so less efficiently.
The mechanism is broad. GHK-Cu binds to the copper ion and acts as a signaling molecule across multiple systems. It activates vascular endothelial growth factor (VEGF) and keratinocyte growth factor (KGF), both of which are critical for hair follicle health and skin repair. It stimulates fibroblast production of collagen and glycosaminoglycans (GAGs), the structural proteins responsible for skin elasticity and wound healing. It also modulates gene expression in ways associated with reduced inflammation, DNA repair, and antioxidant defense.
At Tactus Health, our providers prescribe GHK-Cu as a compounded peptide protocol, typically as a subcutaneous injection or topical formulation, depending on the primary application. It is most commonly used for hair restoration alongside finasteride, skin rejuvenation, and as part of a broader anti-aging peptide protocol.
Plasma GHK-Cu at age 60 is less than half what it was at 20. The decline correlates with reduced tissue repair capacity, slower wound healing, thinning skin, and hair follicle regression, all processes GHK-Cu directly regulates.
GHK-Cu and Hair Loss: The Growth Factor Side
Male pattern hair loss is primarily driven by DHT shrinking hair follicles. Finasteride addresses the DHT side. GHK-Cu addresses the other side: stimulating the growth factors that encourage follicles to increase in size and produce thicker, longer hair. VEGF increases blood supply to follicles. KGF directly stimulates follicle epithelial cell proliferation.
Studies show GHK-Cu increases follicular size and stimulates hair growth in a mechanism completely independent of the DHT pathway. This is why it pairs so effectively with finasteride: one removes the suppressive signal, the other amplifies the regenerative signal. Men who have been on finasteride for 12+ months and reached a plateau often see renewed progress when GHK-Cu is added.
- Activates VEGF to increase blood supply to hair follicles
- Stimulates KGF for follicle epithelial cell proliferation
- Increases follicle size in miniaturized follicles
- Anti-inflammatory effect reduces scalp inflammation that suppresses follicles
- Directly complementary to finasteride (separate mechanism)
Collagen, Elasticity, and Wound Healing
GHK-Cu is one of the most studied peptides in skin biology. It stimulates fibroblasts to produce collagen and glycosaminoglycans (GAGs), the structural proteins responsible for skin firmness and moisture retention. It also reduces the activity of matrix metalloproteinases (MMPs), enzymes that break down existing collagen. The result is both increased production and decreased degradation.
Clinical studies show measurable improvements in skin elasticity, reduced fine line depth, and improved skin density with topical and systemic GHK-Cu. Its wound healing properties are well established: GHK-Cu accelerates re-epithelialization, increases blood vessel formation in healing tissue, and reduces scarring. These same mechanisms that repair wounds also drive aesthetic improvement in aging skin.
- Stimulates fibroblast collagen and GAG production
- Reduces MMP activity, slowing collagen degradation
- Improves skin elasticity and density measurably
- Reduces fine line depth with consistent use
- Accelerates wound healing and reduces scar formation
Gene Expression, DNA Repair, and Inflammation
Beyond hair and skin, GHK-Cu has demonstrated effects at the gene expression level that extend to systemic aging processes. Research by Pickart and Margolina showed GHK-Cu modulates the expression of over 4,000 human genes, with effects concentrated in pathways governing anti-inflammatory response, antioxidant defense, DNA damage repair, and mitochondrial function.
The anti-inflammatory effects are particularly relevant for men on TRT or GLP-1 protocols, where systemic inflammation is a common co-factor. Chronic low-grade inflammation suppresses growth hormone secretion, accelerates tissue breakdown, and impairs recovery. GHK-Cu’s anti-inflammatory signaling works upstream of many of these processes, making it a meaningful addition to a broader optimization protocol rather than a standalone cosmetic treatment.
- Modulates over 4,000 genes in aging-related pathways
- Reduces systemic inflammation via NF-kB pathway modulation
- Supports DNA damage repair signaling
- Antioxidant: stimulates superoxide dismutase activity
- Supports mitochondrial function and cellular energy production
Testosterone optimization addresses hormonal deficiency. GHK-Cu addresses the cellular and tissue repair systems that age independently of hormones. Many patients on TRT who add GHK-Cu report improved skin quality, faster recovery from exercise, and better wound healing alongside the hormonal benefits of TRT.
Significant weight loss from GLP-1 therapy can accelerate skin laxity and reduce collagen density. GHK-Cu’s collagen stimulation and skin elasticity effects are a meaningful complement for patients in active weight loss phases.
What Research Shows
Selected findings from the clinical literature on GHK-Cu. This is a well-studied peptide with a substantial body of published research.
How GHK-Cu Treatment Works at Tactus Health
Dr. Ashar N.
Dr. Ashar holds a Doctor of Nursing Practice and two national board certifications, one in family practice and one in psychiatric mental health.
She founded Tactus Health to close the gap she watched her own family fall through: symptoms that were real, labs that came back normal, and no one willing to connect the two.
She is responsible for the protocols our medical team follows, and for the training of the clinicians who deliver them. Holding both certifications is why those protocols treat hormones, mood, sleep and metabolism as one system rather than five separate appointments.
GHK-Cu Peptide FAQ
Each peptide has a distinct mechanism. BPC-157 is primarily a tissue and gut repair peptide with protective effects on tendons, ligaments, and the gastrointestinal tract. Sermorelin stimulates growth hormone release from the pituitary. GHK-Cu is a copper-binding peptide that activates growth factors (VEGF, KGF) and modulates gene expression across multiple aging-related pathways, with the strongest clinical evidence for hair follicle stimulation, skin collagen synthesis, and wound healing. They are not interchangeable and can be used together in a layered protocol.
Timeline varies by application. Skin elasticity and texture improvements are typically noticeable within 6-8 weeks of consistent use. Hair follicle changes require longer, with meaningful results visible at 3-6 months since hair growth cycles are slow. Systemic anti-inflammatory and antioxidant effects are harder to measure subjectively but are occurring alongside the visible changes. Dr. Ashar schedules a follow-up at 8-12 weeks to assess early response and adjust the protocol if needed.
GHK-Cu has a well-established safety profile across decades of research. It is a naturally occurring peptide that your body already produces. Side effects at therapeutic doses are uncommon: mild injection site reactions (redness, transient swelling) can occur with subcutaneous injection. Topical formulations are generally very well tolerated. Allergic reactions are rare. Because copper is a component, patients with Wilson’s disease or copper metabolism disorders should not use GHK-Cu. Our providers review your health history before prescribing.
Yes, and the combination is specifically recommended for hair restoration. Finasteride blocks DHT to stop follicle miniaturization. GHK-Cu activates VEGF and KGF to stimulate follicle recovery and growth. They work through completely separate mechanisms with no known negative interaction. Men who have been on finasteride for 12 or more months and are no longer seeing progression in regrowth often benefit most from adding GHK-Cu, as the protective mechanism is established and the regenerative mechanism can now take effect.
It depends on your goals. Topical GHK-Cu delivers the peptide directly to the skin or scalp and is effective for localized skin rejuvenation and hair follicle stimulation. Subcutaneous injection provides systemic exposure, which is relevant for the gene expression, anti-inflammatory, and anti-aging applications beyond the skin surface. For patients who want both hair and systemic benefits, our providers may prescribe both. For patients focused purely on skin or scalp, topical alone is a reasonable starting point.
GHK-Cu is not FDA-approved and is prescribed off-label via licensed compounding pharmacy. It is a naturally occurring peptide with a well-established research profile. Not appropriate for patients with Wilson’s disease or copper metabolism disorders. Mild injection site reactions may occur with subcutaneous administration. GHK-Cu does not replace standard medical care for hair loss, skin conditions, or systemic disease; it is a complementary peptide protocol. All prescriptions require a clinical consultation with Dr. Ashar. Telehealth available for Georgia patients. Individual results vary and are not guaranteed.
One Peptide.
Hair, Skin, and Cellular Health.
Free consultation with Dr. Ashar. Our medical team reviews your goals and builds a GHK-Cu protocol that fits your existing treatments.